Clinical Trial Update: Observational Study in CLL Patients Receiving BR

View source ↗

Summary

This entry notes the completion of an observational study in chronic lymphocytic leukemia patients treated with the BR regimen (bendamustine plus rituximab), sp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia

Drugs mentioned

• Bendamustine (Bendamustine)
• Rituximab (rituximab)

Snippet

Sponsor: Czech CLL Study Group | Conditions: Chronic Lymphocytic Leukemia | Status: COMPLETED